The EU will carry out its assessment of FDA based on:
(i)
The performance of an audit in line with the elements of the Joint Audit Programme taking into account audits performed in the framework of the Pharmaceutical Inspection Convention/Scheme (PIC/S) and audits performed in the context of Article 111(b)(1) of Directive 2001/83/EC.
(ii)
An assessment of the equivalence of legislative and regulatory GMP requirements.